Oxidative stress and inflammation in diabetic nephropathy: role of polyphenols.
Jin Q, Liu T, Qiao Y, Liu D, Yang L, Mao H, Ma F, Wang Y, Peng L, Zhan Y. · 2023
Read Oxidative stress and inflammation in diabetic nephropathy: role of polyphenols. by Jin Q, Liu T, Qiao Y, Liu D, Yang L, Mao H, Ma F, Wang Y, Peng L, Zhan Y. (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc10401049.txt.
Introduction
Jin and co-authors reviewed in 2023 how plant compounds may protect kidneys in diabetes. Diabetes can scar the kidneys, a harm called diabetic nephropathy. It often ends in full kidney failure. Two forces drive the harm: cell stress from reactive oxygen, and swelling that feeds back on that stress.
The loop injures key kidney cells and lays down scar tissue. Jin focuses on polyphenols, plant compounds that can calm both forces. Named cases include quercetin, resveratrol, and curcumin. They act on switches such as Nrf2 and NF-κB, which steer stress and swelling. Usual drugs for this harm have weak effects, Jin notes. Much still needs proof before plant compounds enter routine care.
Catalog record
| CREATOR | Jin Q, Liu T, Qiao Y, Liu D, Yang L, Mao H, Ma F, Wang Y, Peng L, Zhan Y. |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 88 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Oxidative stress and inflammation in diabetic nephropathy: role of polyphenols By Qi Jin, Tongtong Liu, Yuan Qiao, Donghai Liu, Liping Yang, Huimin Mao, Fang Ma, Yuyang Wang, Liang Peng, Yongli Zhan Published in: Frontiers in Immunology DOI: 10.3389/fimmu.2023.1185317 ABSTRACT Abstract Diabetic nephropathy (DN) often leads to end-stage renal disease. Oxidative stress demonstrates a crucial act in the onset and progression of DN, which triggers various pathological processes while promoting the activation of inflammation and forming a vicious oxidative stress-inflammation cycle that induces podocyte injury, extracellular matrix accumulation, glomerulosclerosis, epithelial-mesenchymal transition, renal tubular atrophy, and proteinuria. Conventional treatments for DN have limited efficacy. Polyphenols, as antioxidants, are widely used in DN with multiple targets and fewer adverse effects. This review reveals the oxidative stress and oxidative stress-associated inflammation in DN that led to pathological damage to renal cells, including podocytes, endothelial cells, mesangial cells, and renal tubular epithelial cells. It demonstrates the potent antioxidant and anti-inflammatory properties by targeting Nrf2, SIRT1, HMGB1, NF-κB, and NLRP3 of polyphenols, including quercetin, resveratrol, curcumin, and phenolic acid. However, there remains a long way to a comprehensive understanding of molecular mechanisms and applications for the clinical therapy of polyphenols. Keywords: polyphenols, quercetin, resveratrol, curcumin, diabetic nephropathy, oxidative stress, inflammation INTRODUCTION Diabetes mellitus (DM) is a complicated chronic disease described by glucose dysregulation that is caused by absolute or relative defects, including type 1 diabetes (T1D) and type 2 diabetes (T2D). The global prevalence indicates that the number of DM is below half a billion individuals and is projected to increase by 25% and 51% in 2030 and 2045, respectively, putting enormous pressure on healthcare systems worldwide (1). As a complication of DM, diabetic nephropathy (DN), also called diabetic kidney disease (DKD), is the primary reason for chronic kidney disease (CKD) and even end-stage renal disease (ESRD), which is related to increased morbidity and mortality in patients with diabetes. Moreover, approximately 30%-40% of diabetic patients with DN (2). Patients with DN require maintenance dialysis or a kidney transplant. However, these therapy approaches bring a considerable economic and psychological burden and consume substantial medical resources. Therefore, promoting the amelioration of DN is of vital clinical significance (3). The pathogenesis of DN is complicated and still needs to be determined. It has been proven that rigorous management of blood pressure and blood glucose cannot prevent the progression of DN to ESRD, nor can it prevent DN-related deaths. Developing the understanding and research of DN’s pathogenesis is crucial for expanding new methods for DN (4). Multiple pathways and mediators, including oxidative stress, inflammation, and angiotensin II (Ang-II), are involved in the incidence and progression of DN, of which oxidative stress is the most prominent (5, 6). Chronic hyperglycemia induces oxidative stress, promotes excess reactive oxygen species (ROS) production, reduces antioxidant capacity, induces the damage of oxidative stress in DNA and proteins, and stimulates the immune system to release inflammatory mediators and cytokines that affect glomerular capillaries and changes in renal tubular structure and function, thereby exacerbating renal and systemic damage. High glucose (HG)-induced overproduction of ROS is the primary initiator of cell damage in diabetes and its complications. For DN, although several therapies have been developed (7), such as Sodium-glucose cotransporter 2 (SGLT2), which effectively reduces inflammation and oxidative stress and has been shown to reduce the risk of major adverse events and progression of renal disease in patients with T2D, the ultimate treatment effect is not satisfactory (8). Natural products, primarily from herbal sources, have long been explored as sources of drugs to treat a variety of major diseases. To date, significant efforts have been made to support and validate the potential effectiveness of natural and synthetic products in experimental studies and clinical applications, and indicating the antioxidant effects for kidney (9, 10). In preclinical studies, many natural products have recently been reported to alleviate kidney disease by modulating oxidative stress and inflammation (11). As a natural product, polyphenols are widely distributed in most plants and classified as phenolic acids, flavonoids, stilbenes, and lignans according to their structural properties (12).Nuclear factor E2-related factor 2 (Nrf2) is a significant regulator of antioxidant enzymes that protect the body from oxidative stress and inflammation, and Nrf2/antioxidant response element (ARE) signaling has been suggested as a promising target against oxidative stress-mediated diseases, such as diabetes and fibrosis. Dietary polyphenols, such as resveratrol, curcumin, and quercetin, can modulate Nrf2 signaling by mediating various kinases upstream of Nrf2 and also directly activate the expression of Nrf2 as well as downstream targets, such as heme oxygenase 1(HO-1) superoxide dismutase(SOD), and catalase (CAT), to inhibit oxidative stress and regulate inflammatory mediators (13–15). Polyphenols exhibit anti-diabetic potential by reducing intestinal glucose absorption, increasing insulin secretion from pancreatic cells, and modulating gut microbiota and its metabolites (16–19). Natural polyphenols have wide-ranging pharmacological activities, particularly antioxidant activity and free radical-scavenging ability; moreover, they have been gradually used in the research of DN in recent years (20). This review provides a comprehensive summary of oxidative stress and oxidative stress-induced inflammation in DN and polyphenols targeting oxidative stress and inflammation to delay the progression of DN, which provides new insights into polyphenols as promising drug candidates for DN. OXIDATIVE STRESS AND INFLAMMATION IN DN Role of oxidative stress 2.1. Oxidative stress is defined as an excessive accumulation of ROS caused by an imbalance between oxidants and antioxidants, resulting in oxidative damage to the body. Moderate ROS-mediated damage can usually be reversed, but excessive ROS production beyond the self-regulatory process often leads to irreversible damage to cellular function or death (21).ROS includes superoxide anion, hydrogen peroxide (H2O2), nitric oxide (NO), hydroxyl radical, and peroxynitrite (22). Mitochondria induce the production of ROS through the mitochondrial respiratory chain, which is the primary source of ROS. Other sources include nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX), changes in glucose metabolism, including polyol pathway flux, and changes in hemodynamics, advanced glycation end products (AGEs), and protein kinase C (PKC) (23, 24). Basal ROS levels are critical for maintaining various cellular tissue functions, such as gene expression, molecular transcription, and signaling transduction (25). However, excessive ROS accelerates pathological states, including the progression of DN, whereas the antioxidant defense system is activated to eliminate ROS generated from varied sources. Antioxidant enzymes include SOD, glutathione peroxidase (GSH-Px), CAT, glutathione reductase (GR), and paraoxonase (26). As markers of oxidative damage, malondialdehyde (MDA) and protein carbonyl can exacerbate oxidative damage in the body. Oxidative stress significantly affects the cause, onset, and process of DN, and hyperglycemia triggers the activation of the polyol pathway, AGEs, the receptor for advanced glycation end products (RAGE), and PKC. AGEs-RAGE signaling pathway activation potentiates the action of NOX and stimulates the production of ROS (27). Subsequently, ROS further interacted with NOX, aggravating the production of ROS (28). DN is associated with hypoxia, the generation of Ang II, and the production of ROS, leading to actin cytoskeleton reorganization of the podocyte, which induces podocyte injury, disrupts the glomerular filtration barrier and triggers proteinuria (29). Moreover, Ang II interferes with the formulation of ROS via the PKC/NADPH oxidase pathway, and ROS production is inhibited following the knockdown of PKC (30). Oxidative stress and inflammation 2.2. Factors such as hyperglycemia and hypoxia induce oxidative stress and inflammatory responses. Additionally,